Wish list

Print

Do you need progressive lenses, distance spectacles or are computer spectacles the better solution?

Spectacles consultant

Do you need progressive lenses, distance spectacles or are computer spectacles the better solution?

Find optician

You can attach your wish list directly to your appointment booking.

Corporate structure

The Rodenstock Executive Board and key figures.

The Rodenstock Company

At the heart of Rodenstock's business strategy is the patented DNEye® Pro technology, with which Rodenstock is the first company to measure the individual shape and size of each eye and produce individualised spectacle lenses, so-called Biometric Intelligent Glasses (B.I.G. VISION®), from thousands of data points.

Founded in 1877 and headquartered in Munich, Germany, the company employs about 5.000 people worldwide and is represented by sales offices and distribution partners in more than 85 countries. Rodenstock is operating with 6 central production plants to secure global supply.

Our Board

Rodenstock is led by an experienced management team.

  • CEO

    Marcus Desimoni

    • With Rodenstock since 2021
    • Has held leading positions in various companies and countries: Siemens, Sivantos Audiology, GN Hearing
    • More than 20 years of experience

  • CFO

    Dr. Mani Herold

    • With Rodenstock since 2023
    • Extensive international work experience (incl. former CFO) in the area of strategic and operational financial management
    • More than 25 years of experience

  • COO

    Roland Dimbath

    • With Rodenstock since 2006
    • Previously worked at Rodenstock as Head of Sales and Operations Eastern Europe and Head of Logistics and Purchasing
    • More than 20 years of experience

  • EVP Innovation

    Dr. Dietmar Uttenweiler

    • With Rodenstock since 2003
    • Long-standing Rodenstock employee with extensive professional experience and expertise
    • More than 20 years of experience

  • EVP Marketing & Strategy

    Catherine Stahl

    • With Rodenstock since 2024
    • Extensive international industry and marketing experience in the med-tech sector
    • More than 20 years of professional experience

Our corporate structure

In 2002, Rodenstock set the course towards a corporate structure suitable for the capital market by transforming into a GmbH (limited liability company). In June 2003, Permira Beteiligungsberatung GmbH became the first non-family financial investor. In 2007, the European investment company Bridgepoint took over the shares held by the Permira funds. In 2015, Compass Partners joined Rodenstock as an additional investor.

Apax Funds acquired their shares in March 2021. Apax Funds will support Rodenstock's management in accelerating the company's growth and driving innovation, digitalisation and effective marketing of its products.